These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14605631)

  • 1. Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer.
    Santos R; Colonias A; Parda D; Trombetta M; Maley RH; Macherey R; Bartley S; Santucci T; Keenan RJ; Landreneau RJ
    Surgery; 2003 Oct; 134(4):691-7; discussion 697. PubMed ID: 14605631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.
    Voynov G; Heron DE; Lin CJ; Burton S; Chen A; Quinn A; Santos R; Colonias A; Landreneau RJ
    Brachytherapy; 2005; 4(4):278-85. PubMed ID: 16344258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is brachytherapy effective for local recurrence control in sublobar resections for non-small-cell lung cancer?
    Patrini D; Lawrence D; Adams B; Panagiotopoulos N
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):677-81. PubMed ID: 26319561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer.
    Birdas TJ; Koehler RP; Colonias A; Trombetta M; Maley RH; Landreneau RJ; Keenan RJ
    Ann Thorac Surg; 2006 Feb; 81(2):434-8; discussion 438-9. PubMed ID: 16427827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Margin and local recurrence after sublobar resection of non-small cell lung cancer.
    El-Sherif A; Fernando HC; Santos R; Pettiford B; Luketich JD; Close JM; Landreneau RJ
    Ann Surg Oncol; 2007 Aug; 14(8):2400-5. PubMed ID: 17505859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublobar resection for the subcentimeter pulmonary nodule.
    Ketchedjian A; Daly B; Landreneau R; Fernando H
    Semin Thorac Cardiovasc Surg; 2005; 17(2):128-33. PubMed ID: 16087080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer.
    Fernando HC; Santos RS; Benfield JR; Grannis FW; Keenan RJ; Luketich JD; Close JM; Landreneau RJ
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):261-7. PubMed ID: 15678034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomic segmentectomy and brachytherapy mesh implantation for clinical stage I non-small cell lung cancer (NSCLC).
    Landreneau JP; Schuchert MJ; Weyant R; Abbas G; Wizorek JJ; Awais O; Reamer MM; Luketich JD; Landreneau RJ
    Surgery; 2014 Feb; 155(2):340-6. PubMed ID: 24314884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublobar resection with intraoperative brachytherapy versus sublobar resection alone for early-stage non-small-cell lung cancer: a meta-analysis.
    Chen E; Wang J; Jia C; Min X; Zhang H
    Interact Cardiovasc Thorac Surg; 2021 Aug; 33(3):377-384. PubMed ID: 34037754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy.
    Colonias A; Betler J; Trombetta M; Bigdeli G; Gayou O; Keenan R; Werts ED; Parda DS
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):105-9. PubMed ID: 20382483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robotic brachytherapy and sublobar resection for T1 non-small cell lung cancer in high-risk patients.
    Blasberg JD; Belsley SJ; Schwartz GS; Evans A; Wernick I; Ashton RC; Bhora FY; Connery CP
    Ann Thorac Surg; 2010 Feb; 89(2):360-7. PubMed ID: 20103299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer.
    Fernando HC; Landreneau RJ; Mandrekar SJ; Nichols FC; Hillman SL; Heron DE; Meyers BF; DiPetrillo TA; Jones DR; Starnes SL; Tan AD; Daly BD; Putnam JB
    J Clin Oncol; 2014 Aug; 32(23):2456-62. PubMed ID: 24982457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma.
    Chen A; Galloway M; Landreneau R; d'Amato T; Colonias A; Karlovits S; Quinn A; Santucci T; Kalnicki S; Brown D
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1057-63. PubMed ID: 10421539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublobar resection with brachytherapy mesh for stage I non-small cell lung cancer.
    Odell DD; Kent MS; Fernando HC
    Semin Thorac Cardiovasc Surg; 2010; 22(1):32-7. PubMed ID: 20813314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy.
    Yu X; Li J; Zhong X; He J
    BMC Cancer; 2015 Oct; 15():656. PubMed ID: 26445227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of sublobar resection (segmentectomy and wedge resection) in the surgical management of non-small cell lung cancer.
    Pettiford BL; Schuchert MJ; Santos R; Landreneau RJ
    Thorac Surg Clin; 2007 May; 17(2):175-90. PubMed ID: 17626396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric and technical aspects of intraoperative I-125 brachytherapy for stage I non-small cell lung cancer.
    Johnson M; Colonias A; Parda D; Trombetta M; Gayou O; Reitz B; Miften M
    Phys Med Biol; 2007 Mar; 52(5):1237-45. PubMed ID: 17301451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032).
    Kent MS; Mandrekar SJ; Landreneau R; Nichols F; Foster NR; DiPetrillo TA; Meyers B; Heron DE; Jones DR; Tan AD; Starnes S; Putnam JB; Fernando HC
    Ann Thorac Surg; 2016 Jul; 102(1):239-46. PubMed ID: 27101729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage treatment of NSCLC recurrence after first-line chemotherapy failure: Iodine-125 seed brachytherapy or microwave ablation?
    Liu B; Wang Y; Tian S; Hertzanu Y; Zhao X; Li Y
    Thorac Cancer; 2020 Mar; 11(3):697-703. PubMed ID: 31995853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublobar versus lobar resection: current status.
    Narsule CK; Ebright MI; Fernando HC
    Cancer J; 2011; 17(1):23-7. PubMed ID: 21263263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.